Ress Life Investments A/S
2.2.2026 17:05:00 CET | Globenewswire | Press release
Ress Life Investments A/S publishes Net Asset Value (NAV)
Ress Life Investments A/S publishes Net Asset Value (NAV)
Ress Life Investments
Nybrogade 12
DK-1203 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 2 February 2026
Corporate Announcement 05/2026
Ress Life Investments A/S publishes Net Asset Value (NAV).
Ress Life Investments A/S publishes the Net Asset Value (NAV) per share as of 15 January 2026.
NAV per share in USD: 2637.26
The performance during the first half of January is -0.05% in USD. The year-to-date net performance is -0.05% in USD.
Assets under management (AUM) are 210.2 million USD.
The NAV per share in EUR is published on the website of Nasdaq Copenhagen under the section AIF Companies and Funds, where the bid and ask prices are published. The daily NAV in EUR is calculated as the most recently published NAV in USD divided by the European Central Bank’s EUR/USD reference rate on the relevant day.
Questions related to this announcement can be made to the company's AIF-manager, Resscapital AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@resscapital.com
Tel + 46 73 660 72 42
Note: The terms for subscription of shares, minimum subscription amount and redemption of shares are provided in the Articles of Association, Information Brochure and in the Key Information Document available on the Company's website, www.resslifeinvestments.com.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Trifork Group AG26.8.2026 17:43:32 CEST | Press release
51/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Scandinavian Tobacco Group A/S26.8.2026 17:20:00 CEST | Press release
Scandinavian Tobacco Group: Interim Report 1 January – 30 June 2026: Progressing with Focus2030 and Full Year 2026 Guidance maintained
Aegon Ltd.26.8.2026 15:50:00 CEST | Press release
Aegon has filed Shareholder Circular for proposed US redomiciliation
ODDIFACT26.8.2026 15:27:59 CEST | Press release
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Værdipapirfonden Independent Invest II26.8.2026 15:03:40 CEST | Pressemeddelelse
Fusion af afdelinger i Værdipapirfonden Independent Invest II
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom